Clinical Trial

CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction)

Name: CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction) — clinical trial record (NCT06910111)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAPTURE

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This clinical investigation is intended to confirm the application of a new intended purpose and a new indication for an already certified medical device. Therefore, it is a pivotal clinical investigation with a confirmatory type of design.

Trial Details

NCT Number	NCT06910111
Lead Sponsor	Certmedica International GmbH Collaborators: Evidilya S.r.l.
Conditions	Atherosclerotic Disease
Enrollment	240 participants
Start Date	2025-04-01
Primary Completion	2026-12 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2025-04-04